MELK inhibitors (SignalChem)

N/A

Report date: 2025/03/20 14:46:55
NME

Base Information

Drug NameMELK inhibitors (SignalChem)
Drug Alias Namematernal embryonic leucine zipper kinase inhibitors (SignalChem)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaternal embryonic leucine zipper kinase inhibitors
TargetsMaternal embryonic leucine zipper kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesSignalchem Lifesciences
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A